159 related articles for article (PubMed ID: 17539826)
1. Structure-activity relationships of melanocortin agonists containing the benzimidazole scaffold.
Todorovic A; Joseph CG; Sorensen NB; Wood MS; Haskell-Luevano C
Chem Biol Drug Des; 2007 May; 69(5):338-49. PubMed ID: 17539826
[TBL] [Abstract][Full Text] [Related]
2. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
[TBL] [Abstract][Full Text] [Related]
3. The 1,4-benzodiazepine-2,5-dione small molecule template results in melanocortin receptor agonists with nanomolar potencies.
Joseph CG; Wilson KR; Wood MS; Sorenson NB; Phan DV; Xiang Z; Witek RM; Haskell-Luevano C
J Med Chem; 2008 Mar; 51(5):1423-31. PubMed ID: 18271518
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH2 at the mouse melanocortin receptors. Part 3: modifications at the Arg position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
Peptides; 2003 Jan; 24(1):73-82. PubMed ID: 12576087
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, structural and functional characterization of novel melanocortin agonists based on the cyclotide kalata B1.
Eliasen R; Daly NL; Wulff BS; Andresen TL; Conde-Frieboes KW; Craik DJ
J Biol Chem; 2012 Nov; 287(48):40493-501. PubMed ID: 23012369
[TBL] [Abstract][Full Text] [Related]
7. A review of melanocortin receptor small molecule ligands.
Todorovic A; Haskell-Luevano C
Peptides; 2005 Oct; 26(10):2026-36. PubMed ID: 16051395
[TBL] [Abstract][Full Text] [Related]
8. Evolution of melanocortin receptors in teleost fish: the melanocortin type 1 receptor.
Selz Y; Braasch I; Hoffmann C; Schmidt C; Schultheis C; Schartl M; Volff JN
Gene; 2007 Oct; 401(1-2):114-22. PubMed ID: 17707598
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of the modified melanocortin peptides responsible for ligand selectivity at the human melanocortin receptors.
Chen M; Georgeson KE; Harmon CM; Haskell-Luevano C; Yang Y
Peptides; 2006 Nov; 27(11):2836-45. PubMed ID: 16730390
[TBL] [Abstract][Full Text] [Related]
10. Feeding effects of melanocortin ligands--a historical perspective.
Irani BG; Haskell-Luevano C
Peptides; 2005 Oct; 26(10):1788-99. PubMed ID: 16046247
[TBL] [Abstract][Full Text] [Related]
11. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
[TBL] [Abstract][Full Text] [Related]
12. [Melanocortin system].
Levitskaia NG; Kamenskiĭ AA
Usp Fiziol Nauk; 2009; 40(1):44-65. PubMed ID: 19326848
[TBL] [Abstract][Full Text] [Related]
13. Chimeras of the agouti-related protein: insights into agonist and antagonist selectivity of melanocortin receptors.
Jackson PJ; Yu B; Hunrichs B; Thompson DA; Chai B; Gantz I; Millhauser GL
Peptides; 2005 Oct; 26(10):1978-87. PubMed ID: 16009463
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Structure-Activity Relationships of Substituted Urea Derivatives on Mouse Melanocortin Receptors.
Singh A; Kast J; Dirain ML; Huang H; Haskell-Luevano C
ACS Chem Neurosci; 2016 Feb; 7(2):196-205. PubMed ID: 26645732
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
[TBL] [Abstract][Full Text] [Related]
17. New ligands for melanocortin receptors.
Kaelin CB; Candille SI; Yu B; Jackson P; Thompson DA; Nix MA; Binkley J; Millhauser GL; Barsh GS
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S19-27. PubMed ID: 19136986
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.
Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ
J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of a Common DPhe
Gimenez LE; Noblin TA; Williams SY; Mullick Bagchi S; Ji RL; Tao YX; Jeppesen CB; Conde-Frieboes KW; Sawyer TK; Grieco P; Cone RD
J Med Chem; 2022 Apr; 65(8):5990-6000. PubMed ID: 35404053
[TBL] [Abstract][Full Text] [Related]
20. Structure⁻Activity Relationships of the Tetrapeptide Ac-His-Arg-(
Schlasner KN; Ericson MD; Doering SR; Freeman KT; Weinrich M; Haskell-Luevano C
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
